Loading organizations...
Based in San Francisco, California, Biologica is a direct-to-consumer women's health company that develops effervescent beverage supplements tailored to specific hormonal stages, including the reproductive years, perimenopause, and postmenopause. The business formulates its daily beverage sachets using ingredients like electrolytes, probiotics, and botanicals to replace multiple traditional pills with stage-specific nutritional support. Rather than focusing strictly on chronological age, the product line addresses symptoms associated with hormonal shifts, such as polycystic ovary syndrome and premenstrual syndrome. Biologica sells its products through a subscription-based e-commerce model, pricing its supplement packages at $70 for one-time purchases or $59 for monthly subscribers. The enterprise launched with $7 million in seed funding led by Addition, alongside participating venture capital firms Greycroft and True Beauty Ventures. Biologica was founded in 2025 by Liz Zwillinger and Allbirds co-founder Joey Zwillinger.
Biologica has raised $7.0M across 1 funding round.
Biologica has raised $7.0M in total across 1 funding round.
Biologica has raised $7.0M in total across 1 funding round.
Biologica's investors include Addition.